Back to Menu
Colorectal Cancer Treatment Modalities
1.Surgical treatment
Complete resection of the tumor and regional lymph nodes, with local excision, segmental colectomy, or total colectomy selected according to tumor location.
2.Minimally invasive surgery
Laparoscopic or robot-assisted procedures are associated with less trauma and faster recovery, with oncologic outcomes comparable to open surgery.
3.Chemotherapy
Regimens such as FOLFOX and FOLFIRI are used as adjuvant or neoadjuvant therapy; adverse effects require active management.
4.Radiotherapy
Primarily used for rectal cancer: preoperative radiotherapy downstages tumors, while postoperative radiotherapy eradicates residual disease or provides palliation.
5.Targeted therapy
Anti-EGFR therapy is used for RAS wild-type tumors; anti-angiogenic agents are also used, with selection guided by molecular testing.
6.Immunotherapy
PD-1 inhibitors are indicated for advanced dMMR/MSI-H disease and can produce durable responses.
7.Local ablative therapy
Radiofrequency or microwave ablation can be used to treat liver and lung metastases, with minimal trauma and rapid recovery.
8.Interventional therapy
Hepatic arterial infusion and/or embolization increases local drug concentration for liver metastases.
9.Supportive care
Comprehensive pain control, nutritional support, and psychological care throughout the treatment course to ensure tolerance and quality of life.
10.Traditional Chinese medicine as adjunct therapy
May help alleviate chemoradiotherapy-related adverse effects and improve symptoms; it should be administered under the guidance of qualified physicians.
11.Multidisciplinary comprehensive management
Surgery, medical oncology, radiation oncology, pathology, and imaging teams jointly develop individualized treatment plans.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that colorectal cancer is preventable and treatable. Early diagnosis and standardized MDT-based comprehensive management (including surgery, chemotherapy, and targeted therapy) are central to improving prognosis. Patients should actively cooperate with treatment and attend regular follow-up to achieve long-term survival.
Colorectal Cancer Treatment Modalities
1.Surgical treatment
Complete resection of the tumor and regional lymph nodes, with local excision, segmental colectomy, or total colectomy selected according to tumor location.
2.Minimally invasive surgery
Laparoscopic or robot-assisted procedures are associated with less trauma and faster recovery, with oncologic outcomes comparable to open surgery.
3.Chemotherapy
Regimens such as FOLFOX and FOLFIRI are used as adjuvant or neoadjuvant therapy; adverse effects require active management.
4.Radiotherapy
Primarily used for rectal cancer: preoperative radiotherapy downstages tumors, while postoperative radiotherapy eradicates residual disease or provides palliation.
5.Targeted therapy
Anti-EGFR therapy is used for RAS wild-type tumors; anti-angiogenic agents are also used, with selection guided by molecular testing.
6.Immunotherapy
PD-1 inhibitors are indicated for advanced dMMR/MSI-H disease and can produce durable responses.
7.Local ablative therapy
Radiofrequency or microwave ablation can be used to treat liver and lung metastases, with minimal trauma and rapid recovery.
8.Interventional therapy
Hepatic arterial infusion and/or embolization increases local drug concentration for liver metastases.
9.Supportive care
Comprehensive pain control, nutritional support, and psychological care throughout the treatment course to ensure tolerance and quality of life.
10.Traditional Chinese medicine as adjunct therapy
May help alleviate chemoradiotherapy-related adverse effects and improve symptoms; it should be administered under the guidance of qualified physicians.
11.Multidisciplinary comprehensive management
Surgery, medical oncology, radiation oncology, pathology, and imaging teams jointly develop individualized treatment plans.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that colorectal cancer is preventable and treatable. Early diagnosis and standardized MDT-based comprehensive management (including surgery, chemotherapy, and targeted therapy) are central to improving prognosis. Patients should actively cooperate with treatment and attend regular follow-up to achieve long-term survival.